Mission
"Treating disease by ferroptosis drug discovery"
Ferroptosis, the mechanism we are targeting, has been reported and attracting attention for its involvement in various diseases such as cancer and Alzheimer's disease.
Through many years of research, we have developed anti-cancer drugs utilizing ferroptosis. We would like to deliver our drug to patients suffering cancers as soon as possible, and we really would like to eradicate cancer and relieve patients. We are promoting development with these feelings in our chest.
And by utilizing the know-how of ferroptosis research, we aim to contribute to creating a society where everyone can live healthily at ease, by developing not only cancer drugs but also drugs for other diseases.
Member
About Us
会社名 | 株式会社FerroptoCure |
所在地 | 東京都千代田区富士見1-3-11 デュープレックス富士見B’s 4F |
TEL | 03-5225-9020 |
設立 | 2022年5月30日 |
資本金 | 600万円 |
事業内容 | 各疾患に対する治療薬の研究開発 |
代表取締役 | 大槻雄士 |